Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
BRCA-Mutated Advanced Ovarian Cancer
.
Show all posts
Showing posts with label
BRCA-Mutated Advanced Ovarian Cancer
.
Show all posts
Friday, January 25, 2019
Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer
›
In continuation of my update on olaparib AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) anno...
›
Home
View web version
